{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:10:28Z","timestamp":1648627828923},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1097\/cad.0b013e3283559fef","type":"journal-article","created":{"date-parts":[[2012,5,21]],"date-time":"2012-05-21T16:25:10Z","timestamp":1337617510000},"page":"S13-S14","source":"Crossref","is-referenced-by-count":0,"title":["Intervention in gastrointestinal stromal tumour with a high risk of malignancy and associated with thalassaemia minor"],"prefix":"10.1097","volume":"23","author":[{"given":"Carles","family":"Pericay Pijaume","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugeni","family":"Saigi Grau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0140-6736(09)60500-6","article-title":"Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.","volume":"373","author":"DeMatteo","year":"2009","journal-title":"Lancet"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(09)70242-6","article-title":"Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis.","volume":"10","author":"Gold","year":"2009","journal-title":"Lancet Oncol"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1586\/era.09.171","article-title":"Towards global consensus in the treatment of gastrointestinal stromal tumor.","volume":"10","author":"Reichardt","year":"2010","journal-title":"Expert Rev Anticancer Ther"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/CCO.0b013e32833aaaad","article-title":"Neoadjuvant and adjuvant imatinib treatment in gastrointestinal stromal tumor: current status and recent developments.","volume":"22","author":"Reynoso","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.2165\/11205000-000000000-00000","article-title":"Imatinib: as adjuvant therapy for gastrointestinal stromal tumour.","volume":"70","author":"Sanford","year":"2010","journal-title":"Drugs"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CAD.0b013e3283559fef","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:17:29Z","timestamp":1620947849000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001813-201206001-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3283559fef","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}